ArticleBrain structure & function2026
A Zdhhc22-mCherry BAC transgenic mouse line reveals neuronal expression dynamics in the developing and adult CNS.
Article in Brain structure & function, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The DHHC palmitoyltransferase Zdhhc22 is known to play a role in neuronal differentiation, synaptic regulation, and brain development. While transcriptomic data hint at region-specific expression, its exact spatiotemporal and cell-type distribution in the mammalian brain is unclear. For this purpose, we generated a bacterial artificial chromosome (BAC) transgenic mouse line that expresses the mCherry fluorescent reporter driven by the Zdhhc22 promoter. We then analyzed Zdhhc22 expression from embryonic day 13.5 (E13.5) through adulthood. mCherry fluorescence was detected in many brain regions, including the cortex, thalamus, midbrain, piriform cortex, and brainstem. Interestingly, a dynamic developmental gene expression pattern was observed: Zdhhc22 expression was initially restricted to the cortical marginal zone between E13.5 and E15.5, it then expanded into deeper cortical layers by E17.5, and at postnatal day 0 (P0), it persisted in deep layers while also appearing in a new subset of cortical plate neurons. Through co-immunostaining, mCherry expression was found to be predominantly neuronal, showing strong co-localization with NeuN and minimal overlap with glial cells. In the cortex, Zdhhc22 expression showed no co-localization with CUX1 or CTIP2 but did partially overlap with FOG2, a marker for layer VI pyramidal neurons. A particularly striking finding was that nearly all marginal zone mCherry-positive cells co-expressed RELN, identifying them as Cajal-Retzius cells. This neuronal specificity was maintained in the adult brain. Our findings validate the Zdhhc22-mCherry BAC transgenic line as a faithful model of endogenous Zdhhc22 expression, providing invaluable insight into its cellular specificity and a powerful new tool for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.